Actively Recruiting
Clinnova-IBD, a Prospective Cohort of Patients With Inflammatory Bowel Disease (IBD)
Led by Luxembourg Institute of Health · Updated on 2025-09-22
100
Participants Needed
1
Research Sites
300 weeks
Total Duration
On this page
Sponsors
L
Luxembourg Institute of Health
Lead Sponsor
L
Luxembourg National Research Fund
Collaborating Sponsor
AI-Summary
What this Trial Is About
This study is part of the Clinnova program. This is a prospective cohort study including patients with IBD recruited at the time of a treatment change. At least 800 participants (recruited in France, Germany and Luxembourg) will be enrolled, of which 100 participants are expected to be recruited in Luxembourg with the present study protocol. The mission of Clinnova is to support the digitalization of healthcare and precision medicine by creating a data-enabling environment for accessing, sharing and analyzing interoperable, high-quality health data. The main hypothesis is that treatment change decided by clinicians is predictable using objective surrogate markers derived from clinical, epidemiological, and omics data. Identifying these objective markers may facilitate future treatment decisions, provide new insights on the molecular causes for differential treatment response, pathogenesis and progression, and potential pointers for improved personalized therapeutic interventions.
CONDITIONS
Official Title
Clinnova-IBD, a Prospective Cohort of Patients With Inflammatory Bowel Disease (IBD)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- 18 years old or older
- Willing and able to comply with study procedures including data and sample collection, visits, and examinations
- Signed informed consent form
- Diagnosed with Crohn's disease or ulcerative colitis at least 3 months before enrollment
- Experienced a significant change in treatment, such as drug dosage change, medication switch, treatment class change, or addition of a drug
- Patients with ostomy or short bowel syndrome are eligible if all criteria are met
You will not qualify if you...
- Any condition that may prevent compliance with the study protocol, including procedures and visits (e.g., mental disability affecting questionnaire completion)
- Not fluent in French, English, or German
- Known pregnancy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Centre Hospitalier de Luxembourg (CHL)
Luxembourg, Luxembourg, L-1210
Actively Recruiting
Research Team
J
Jasmin Schulz, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here